Fintech

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

Prnewswire·April 2, 2026 at 11:30 AM

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

DOJ crypto memo author named interim AG
CoinDesk
Drift crypto exchange remains frozen after attack
PYMNTS
Amazon adds fuel surcharge for sellers
PYMNTS
DOJ Appeals Anthropic AI Ban Restoration
PYMNTS

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

DOJ crypto memo author named interim AG

Drift crypto exchange remains frozen after attack

Amazon adds fuel surcharge for sellers

DOJ Appeals Anthropic AI Ban Restoration